GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Effective Interest Rate on Debt %

Diamyd Medical AB (OSTO:DMYD B) Effective Interest Rate on Debt % : 0.00% (As of Feb. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Diamyd Medical AB's annualized positive value of Interest Expense for the quarter that ended in Feb. 2025 was kr0.97 Mil. Diamyd Medical AB's average total debt for the quarter that ended in Feb. 2025 was kr0.00 Mil. Therefore, Diamyd Medical AB's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2025 was N/A%.


Diamyd Medical AB Effective Interest Rate on Debt % Historical Data

The historical data trend for Diamyd Medical AB's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Effective Interest Rate on Debt % Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.02 0.03

Diamyd Medical AB Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -27.06 34.31 -

Competitive Comparison of Diamyd Medical AB's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Diamyd Medical AB's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Effective Interest Rate on Debt % falls into.


;
;

Diamyd Medical AB Effective Interest Rate on Debt % Calculation

Diamyd Medical AB's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Aug. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Aug. 2023 )+Total Debt  (A: Aug. 2024 ))/ count )
=-1  *  -0.008/( (15.865+30.672)/ 2 )
=-1  *  -0.008/23.2685
=0.03 %

where

Total Debt  (A: Aug. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=15.865 + 0
=15.865

Total Debt  (A: Aug. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=30.672 + 0
=30.672

Diamyd Medical AB's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Nov. 2024 )+Total Debt  (Q: Feb. 2025 ))/ count )
=-1  *  -0.968/( (0+0)/ 1 )
=-1  *  -0.968/0
=N/A %

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Feb. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Diamyd Medical AB  (OSTO:DMYD B) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Diamyd Medical AB Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB Business Description

Industry
Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines